Sherlock Biosciences Revenue and Competitors

Boston, MA USA

Location

$56M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sherlock Biosciences's estimated annual revenue is currently $16.1M per year.(i)
  • Sherlock Biosciences's estimated revenue per employee is $155,000
  • Sherlock Biosciences's total funding is $56M.

Employee Data

  • Sherlock Biosciences has 104 Employees.(i)
  • Sherlock Biosciences grew their employee count by -19% last year.

Sherlock Biosciences's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
VP – Assay DevelopmentReveal Email/Phone
3
VP Clinical & Regulatory AffairsReveal Email/Phone
4
SVP Finance & LegalReveal Email/Phone
5
VP, Biomanufacturing & UK Site OperationsReveal Email/Phone
6
VP Engineering and Product DevelopmentReveal Email/Phone
7
VP Corporate DevelopmentReveal Email/Phone
8
VP Program ManagementReveal Email/Phone
9
Co-Founder, DirectorReveal Email/Phone
10
Associate Director - Head Intellectual PropertyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Sherlock Biosciences?

Sherlock Biosciences aims to disrupt molecular diagnostics with better, faster, affordable tests. With our unique Engineering Biology platforms, we are on the cusp of solving challenges ranging from faster pathogen detection and simpler testing for cancer to improved food safety. We envision a world where our products will enable users to make more effective decisions in any environment, whether in hospitals, industrial settings, the developing world, or at home. Our team and founders include Engineering Biology pioneers with world-leading expertise in CRISPR and Synthetic Biology, diagnostic industry veterans, and disease-area authorities. Together, they provide an unparalleled set of capabilities that are transforming molecular diagnostics in clinical and non-clinical settings.

keywords:N/A

$56M

Total Funding

104

Number of Employees

$16.1M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sherlock Biosciences News

2022-04-19 - CRISPR Technology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

For instance, In May 2020, Sherlock Biosciences announced that it had ... and Drug Administration (FDA) for its Sherlock CRISPR SARS-CoV-2...

2022-04-06 - Sherlock Biosciences Appoints Karen Davies as Chief Development ...

BOSTON, April 7, 2022 /PRNewswire/ -- Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the...

2022-03-22 - Sherlock Biosciences Raises $80 Million in Series B Financing to ...

Sherlock Biosciences is developing products that will empower people to access answers and have more control over their health decisions.

2019-04-23 - Sherlock Biosciences Closes $31M Series A Funding

Sherlock Biosciences, a Cambridge, Mass.-based engineering biology company dedicated to improving diagnostic testing, closed its over $31m Series A funding. The additional funds bring total committed capital to $49m, including a $17.5m non-dilutive grant from the Open Philanthropy Project. Bac ...

2019-04-23 - Sherlock Biosciences Closes $31M Series A

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster, and more affordable, today announced the close of its Series A round, with a total investment of over $31 million from Northpond Ventures, Baidu Ventures ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.1M104-5%N/A
#2
$33.6M104N/AN/A
#3
N/A10421%N/A
#4
$24.9M10416%N/A
#5
$16.1M10412%N/A